Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00112411 · ClinicalTrials.gov registry record · Phase 2
Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
A Phase 2 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00112411: Completed Phase 2 study, sponsored by Teva Branded Pharmaceutical Products R&D.
NCT00112411 is a Phase 2 study that has completed, run by Teva Branded Pharmaceutical Products R&D. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00112411, a Phase 2 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
This study is designed to evaluate the single-dose effectiveness of two bronchodilator inhalers given at two dose levels in pediatric asthma patients.
Interventions
- DRUG Bronchodilator
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-06-30 |
| Est. Completion | 2005-09-30 |
| Phase | Phase 2 |
What the finished NCT00112411 record still lists
NCT00112411 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Bronchodilator is the first listed.
NCT00112411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00112411 about?
NCT00112411 is a clinical study titled "Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics". This study is designed to evaluate the single-dose effectiveness of two bronchodilator inhalers given at two dose levels in pediatric asthma patients.
What is the current status of trial NCT00112411?
This trial is currently completed. It is a Phase 2 study. The study started on 2005-06-30. Estimated completion is 2005-09-30.
What interventions are being tested in trial NCT00112411?
The interventions under investigation include: Bronchodilator (DRUG).
Who is sponsoring clinical trial NCT00112411?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI